Traditional Chinese medicine composition for treating lumbocrural pain and lumbar intervertebral disc protrusion and preparation method thereof

A technology of lumbar intervertebral disc herniation and composition, which is applied in the directions of drug combination, drug delivery, pharmaceutical formulation, etc., can solve the problems of unsatisfactory clinical treatment status, application limitation, toxic and side effects, etc., and achieves improvement of lumbar vertebrae range of motion and good treatment. effect, significant curative effect

Active Publication Date: 2009-06-03
SINOPHARM GRP DEZHONG (FOSHAN) PHARM CO LTD
View PDF0 Cites 15 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0006] The current clinical treatment status of blood stasis and cold-damp type lumbago and leg pain, acute lumbago and leg

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Traditional Chinese medicine composition for treating lumbocrural pain and lumbar intervertebral disc protrusion and preparation method thereof
  • Traditional Chinese medicine composition for treating lumbocrural pain and lumbar intervertebral disc protrusion and preparation method thereof
  • Traditional Chinese medicine composition for treating lumbocrural pain and lumbar intervertebral disc protrusion and preparation method thereof

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0026] The preparation of embodiment 1 granule

[0027] (1) Weigh each raw material according to the following weight: Sanqi 167g, Chishao 556g, Curcuma 556g, Wulingzhi 556g, Safflower 556g, Peach Kernel 445g, Frankincense 278g, Myrrh 278g, Angelica 556g, Zhicaowu 389g, 556g Chuanxiong, 556g Caulis Spatholobus, 556g Cyperus cyperi, 556g Citrus aurantium, 556g Poria cocos, 556g Alisma 556g;

[0028] (2) Take notoginseng and grind it into fine powder, and sieve to obtain material A;

[0029] (3) Take frankincense, myrrh, citrus aurantium, chuanxiong, angelica and add water to extract the volatile oil by steam distillation, and the obtained volatile oil is material B; the remaining medicinal residue after extracting the volatile oil is mixed with red peony root, turmeric, wulingzhi, safflower . After 1.5 hours, combine the decoction and filter to obtain the filtrate;

[0030] (4) The filtrate obtained in step (3) is concentrated to an extract with a relative density of 1.16-1....

Embodiment 2

[0033] The preparation of embodiment 2 liquor

[0034] (1) Weigh each raw material according to the following weight: Panax notoginseng 84g, Chishao 278g, Curcuma 278g, Wulingzhi 278g, Safflower 278g, Peach kernel 223g, Frankincense 139g, Myrrh 139g, Angelica 278g, Zhicaowu 195g, 278g Chuanxiong, 278g Caulis Spatholobus, 278g Cyperus Cyperi, 278g Citrus aurantium, 278g Poria, 278g Alisma;

[0035] (2) Take notoginseng and pulverize it to obtain material A;

[0036] (3) Take frankincense, myrrh, citrus aurantium, chuanxiong, angelica and add water to extract the volatile oil by steam distillation to obtain the volatile oil, which is material B; Mix flowers, peach kernels, Zhicaowu, Caulis Spatholobus, Rhizoma Cyperi, Poria, and Alisma, add 12 times the weight of water to decoct once, decoct for 3 hours, filter the decoction to obtain the filtrate;

[0037] (4) Concentrate the filtrate obtained in step (3) to a relative density of 1.16-1.26 (70°C), let it cool, add ethanol unt...

Embodiment 3

[0039] The preparation of embodiment 3 tablet

[0040] (1) Weigh each raw material according to the following weight: Panax notoginseng 134g, Radix Paeoniae Rubra 445g, Curcuma 445g, Wulingzhi 445g, Safflower 445g, Peach kernel 356g, Frankincense 222g, Myrrh 222g, Angelica 445g, Zhicaowu 311g, 445g Chuanxiong, 445g Caulis Spatholobus, 445g Cyperus cyperi, 445g Citrus aurantium, 445g Poria cocos, 445g Alisma 445g;

[0041] (2) Take notoginseng and grind it into fine powder, and sieve to obtain material A;

[0042] (3) Take frankincense, myrrh, citrus aurantium, chuanxiong, angelica and add water to extract the volatile oil by steam distillation to obtain the volatile oil, which is material B; Mix flowers, peach kernels, Zhicaowu, Caulis Spatholobus, Rhizoma Cyperi, Poria, and Alisma, add water and decoct 3 times; add 9 times the weight of water for the first time, and decoct for 2 hours; add 10 times the weight of water for the second time, Decoct for 2 hours; add 7 times the...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention discloses a traditional Chinese medicine composition for treating lumbocrural pain, lumbar intervertebral disc protrusion, traumatic injury, soft tissue pains and the like and a preparation method thereof. The composition is made from the following bulk drugs by weight: 84-334 parts of notoginseng, 278-1112 parts of red peony root, 278-1112 parts of curcuma root, 278-1112 parts of faeces of flying squirrel, 278-1112 parts of safflower, 223-890 parts of peach kernel, 139-556 parts of frankincense, 139-556 parts of myrrh, 278-1112 parts of angelica, 195-778 parts of prepared aconite root, 278-1112 parts of chuanxiong rhizome, 278-1112 parts of spatholobus stem, 278-1112 parts of cyperus tuber, 278-1112 parts fruit of immature citron, 278-1112 parts of tuckahoe and 278-1112 parts of alisma rhizome. The traditional Chinese medicine composition has stable efficacy on the lumbocrural pain, the lumbar intervertebral disc protrusion, the traumatic injury and other soft tissue pains and the like, and has safe clinical application.

Description

technical field [0001] The invention relates to a pharmaceutical composition, in particular to a Chinese medicinal composition prepared from Chinese herbal medicines for treating low back pain, lumbar disc herniation, bruises or other soft tissue pains. The present invention also relates to the traditional Chinese medicinal composition The invention relates to a preparation method of a compound, belonging to the field of traditional Chinese medicines. Background technique [0002] Low back pain is a common and frequently-occurring disease. According to statistics, about 55% of the total population has suffered from low back pain. The blood stasis and cold-damp type of low back and leg pain has a sharp onset, severe symptoms, and great pain for the patient. difficulty. [0003] "Nei Jing" classifies low back pain, lumbago and leg pain into the category of muscle and bone arthralgia. "Su Wen · Stabbing Lumbago" pointed out: "The veins of the balance collaterals cause lumbago...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
IPC IPC(8): A61K36/9066A61K9/06A61K9/08A61K9/10A61K9/14A61K9/16A61K9/20A61K9/48A61K9/70A61P29/00A61P19/08A61P19/04A61K35/24
Inventor 蒋位庄
Owner SINOPHARM GRP DEZHONG (FOSHAN) PHARM CO LTD
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap